Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.
Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.
The majority of patients with the PSC have Inflammatory Bowel Disease (IBD). In this presentation, Dr. Laura Raffals, Associate Professor of Medicine, Mayo Clinic College of Medicine provides a comprehensive review of the epidemiology, diagnosis, outcomes and management of IBD among PSC patients.
View the [...]
Female patients with the PSC and inflammatory bowel disease (IBD) have unique health and disease issues to deal with.
During the 15th Annual Conference of the “PSC Partners Seeking a Cure”", Dr. Alina Allen, Assistant Professor of Medicine, Mayo Clinic College of Medicine, and Dr. Laura Raffals, Associate [...]
On May 21-23, 2019, the 15th Annual Conference of the “PSC Partners Seeking a Cure” took place in Rochester, Minnesota. More than 315 patients and family members attended the meeting. We are honored and grateful that “PSC Partners Seeking a Cure” choose Rochester and Mayo Clinic as their destination [...]
In a study published this month in Gut, T. Liwinski, et al., reports on the differences of the microbiome and bile acid composition seen in the bile fluid of patients with PSC compared with healthy controls. 43 patients with PSC and 22 controls were included and bile specimens were [...]
Recently, we have made the decision to include periodically in our PSC blog commentaries of selected clinical studies published by other groups. This tactic aims at keeping the followers of this blog informed about current efforts of the academic community at large to better understand and treat PSC.